The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Concord Drugs Ltd

Concord Drugs Ltd

BSE 538965 · NSE CONCORD · ISIN INE858L01010 · Group X · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹81.13

+1.78%

BSE close, 28 August 2026

Market cap

₹106.89 cr

1.3 cr shares · Micro cap

Free float

₹47.59 cr

as published

P/E · P/B

52.0× · 3.15×

EPS ₹1.56 · BV ₹25.76

FY25-26 rev / PAT

75.85 / 1.04

₹ cr, as filed

Filings, window

14

2 selected · 14%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹56.17 52-WK HIGH ₹92.52 ₹81.13 69% of range
Against 52-week high-12.3%
Against 52-week low+44.4%
Day change+1.78%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹1.56
Price / earnings52.01×
Price / book3.15×
Book value — derived, price ÷ P/B₹25.76
Return on equity6.05%
Operating margin10.73%
Net margin5.32%

Consistency check

P/B ÷ P/E, which must equal ROE
6.06%
ROE as published
6.05%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 20.89 1.11 0.84 10.73% 5.32%
Mar-26 · Q 35.55 0.52 0.46 4.03% 1.45%
FY25-26 75.85 1.04 0.93 5.62% 1.37%

Quarter on quarter

Revenue, quarter on quarter
-41.2%
Net profit, quarter on quarter
+113.5%
Operating margin, quarter on quarter
+670 bps

Disclosure profile 14 filings in the window

0 median 17.0 p75 · 25 sector max 52 14 39th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Results1
Selected sub-total2
Procedural
AGM / EGM3
Newspaper Publication2
Annual Report1
Board Meeting1
Book Closure1
General1
Outcome1
Record Date1
Trading Window1
Procedural sub-total12
Total14

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

14 filings · 2 selected · busiest 2026-09-07

Filing rhythm · the twelve most recent

2026-08-102026-10-01

SelectedProcedural

Filings

14 in the window · 2 earlier on record

  1. 1 October 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Annual general meeting -Scrutinizer's Report

    AGM/EGM / AGM View filing →

  2. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Summary Proceedings of AGM

    AGM/EGM / AGM View filing →

  3. 25 September 2026 ·

    Trading Window

    Closure of Trading Window

    Closure of trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  4. 9 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Copies of News paper publications of the Notice of the 31st AGM to be held on 30.09.2026

    Company Update / Newspaper Publication View filing →

  5. 7 September 2026 ·

    General

    Letter To Shareholders

    Letter to members as per regulation 36(1)(b)

    Company Update / General View filing →

  6. 7 September 2026 ·

    Record Date

    Intimation Of Record Date For 31St AGM

    Record date for Annual general meeting

    Corp. Action / Record Date View filing →

  7. 7 September 2026 ·

    Book Closure

    31St AGM

    Book Closure for AGM to be held on 30.09.2026

    Corp. Action / Book Closure View filing →

  8. 7 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    31st Annual Report of the Company

    Others / Reg. 34 (1) Annual Report View filing →

  9. 7 September 2026 ·

    AGM / EGM

    31St Annual General Meeting

    AGM to be held on 30.09.2026 at 09:00 AM

    AGM/EGM / AGM View filing →

  10. 7 September 2026 ·

    Outcome

    Board Meeting Outcome for Annual General Meeting To Be Held On 30.09.2026

    Company has approved the notice and proposed to hold 31st AGM on 30.09.2026

    Others / Outcome without intimation View filing →

  11. 12 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Copy of News-paper publications for quarterly results ended 30th June 2026.

    Company Update / Newspaper Publication View filing →

  12. 10 August 2026 ·

    Results

    Financial Results For Quarter Ended 30 June 2026

    Board of Directors have approved stand alone and consolidated Un-audited financial results for 30th June 2026

    Result / Financial Results View filing →

  13. 10 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting

    Outcome of Board meeting

    Board Meeting / Outcome of Board Meeting View filing →

  14. 3 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Quarterly Results

    Concord Drugs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Quarterly Results

    Board Meeting / Board Meeting View filing →

RSS feed for Concord Drugs Ltd · the 50 most recent filings